摘要
We examined the inhibitory effects of HAQ (His-Ala-Gln) peptide on type-1 allergy in vitro and in vivo. HAQ peptide inhibited -hexosaminidase release and intracellular Ca2+ levels of rat basophilic leukemia RBL-2H3 cells. Oral administration of a HAQ peptide-added diet (1mg/mouse/administration) to C3H/HeJ mice for 14days led to significant suppression of allergic symptoms, but did not reduce allergen-specific IgE or IgG(1).
- 出版日期2017-2